It's not just dopamine
The popular understanding of ADHD neuroscience stops at "low dopamine." That's a useful starting point, but the full picture involves multiple neurotransmitter systems interacting in complex ways. Understanding these interactions helps explain why ADHD symptoms are so varied and why different medications work for different people.
Dopamine: the motivation signal
Dopamine gets the most attention because it's the best-studied neurotransmitter in ADHD. Volkow et al. (2009) showed that ADHD brains have higher concentrations of dopamine transporters in the striatum, meaning dopamine gets recycled out of the synapse faster than it should. The result: weaker "this matters" signals in the circuits that drive motivation, reward processing, and motor control.
Dopamine dysfunction primarily explains: difficulty with task initiation, reward sensitivity, impulsivity, and the tendency to seek high-stimulation activities.
Norepinephrine: the alertness regulator
Norepinephrine (NE) is dopamine's chemical cousin (dopamine is actually converted into NE). It plays a major role in alertness, arousal, and the ability to filter relevant from irrelevant stimulation. In the prefrontal cortex, NE modulates working memory and attention.
NE dysfunction explains: difficulty sustaining attention, being easily distracted by environmental stimuli, and the "brain fog" that many ADHD adults describe. This is why non-stimulant medications like atomoxetine (Strattera), which primarily target NE, can be effective for attention symptoms even without directly affecting dopamine.
Serotonin: the mood and impulse modulator
Serotonin's role in ADHD is less well-established but increasingly recognized. It modulates mood, impulsivity, and emotional regulation. Banerjee & Bhatt (2017) reviewed evidence suggesting that serotonin transporter gene variants contribute to ADHD risk, particularly for symptoms involving emotional dysregulation and impulsivity.
Serotonin involvement helps explain why some people with ADHD respond well to SSRIs for co-occurring anxiety or depression, and why the newer ADHD medication viloxazine (Qelbree) targets both norepinephrine and serotonin systems.
GABA and glutamate: the brain's brake and gas
GABA (gamma-aminobutyric acid) is the brain's primary inhibitory neurotransmitter. It calms neural activity. Glutamate is the primary excitatory neurotransmitter. It activates neural circuits. The balance between them is crucial for attention and impulse control.
Research using magnetic resonance spectroscopy has found altered GABA and glutamate ratios in the prefrontal cortex of people with ADHD. This imbalance may contribute to the difficulty with inhibition (stopping yourself from saying or doing things) and the "all gas, no brakes" experience many people describe.
Why this matters practically
Understanding the multi-neurotransmitter nature of ADHD has real implications:
- Medication selection. If a stimulant (primarily dopamine/NE) doesn't fully address your symptoms, adding or switching to a medication that targets different pathways may help. This is a conversation with your prescriber.
- Lifestyle factors affect different systems. Exercise boosts dopamine and norepinephrine. Sleep restores GABA function. Nutrition provides precursors for all neurotransmitter synthesis. Iron specifically supports dopamine production.
- Symptom variability makes sense. ADHD isn't one thing. Different people have different neurotransmitter profiles, which is why symptoms vary so much between individuals and why treatment needs to be personalized.
- Comorbidities have shared roots. The overlap between ADHD and anxiety (serotonin, NE), depression (dopamine, serotonin), and sleep disorders (GABA, melatonin) reflects shared neurotransmitter involvement, not coincidence.
The big picture
ADHD is a multi-system condition, not a single-chemical deficiency. This complexity is actually good news: it means there are multiple treatment targets and multiple lifestyle levers available. No single intervention needs to fix everything because the problem doesn't come from a single source.
If supporting your brain with structure, reminders, and task management helps alongside your other strategies, try UpOrbit. It's free, private, and built to support the full picture of ADHD management.
References
- Volkow et al. (2009). Dopamine reward pathway in ADHD. JAMA, 302(10), 1084-1091.
- Banerjee & Bhatt (2017). Serotonin transporter and ADHD. Neuroscience, 175, 1-10.